HNL News

August 08, 2022

Familial Hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
July 06, 2022

A Roadmap to Targeted Therapy in Oncology

Dr. Hina Sheikh, Co-Chief, Section of Dermatopathology at HNL Lab Medicine, contributed on this case report, along with colleagues in medical, surgical and radiation oncology at LV Health Network.
Read More
June 29, 2022

Automation in the Clinical Laboratory

Clinical laboratory automation is essential to deliver high quality results in the most cost effective and efficient way.  Automation requires minimal operator intervention and helps to increase productivity, tracking of specimens within the laboratory, decreased turnaround times, improvements in specimen handling, improved laboratory safety, and minimizes errors.
Read More
June 17, 2022

LYME Disease

As you continue to spend more time outside enjoying the weather, you’ll be sharing your space with some critters you’ll want to be aware of. Deer ticks can carry the bacteria that causes Lyme disease, which can have a critical impact on your health if untreated.
Read More
June 15, 2022

Men's Health Month

In 1994, Congress designated the month of June as Men's Health Month to heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys.
Read More
HNL News

December 07, 2021

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, announces the promotion of two senior leaders within the company to new executive roles.

Kim Delaney Kim Delaney transitions from her role as director of sales to become the company’s first vice president of sales. She brings more than two decades of experience in healthcare sales and sales management to her new position.  

Delaney’s responsibilities include integrating the call center into the sales organization to support existing clients and transforming the sales team in the targeting of new business opportunities. Delaney and her team will accomplish this through improved technology, operational enhancements and partnering with lab operations to offer innovative testing capabilities. Follow Kim

 

Brian FanningBrian Fanning joins the organization’s executive team as its first vice president of patient experience. Fanning spent the first 10 years of his career in accounting and finance before moving into healthcare product marketing for the past 15 years. 

Fanning will lead HNL Lab Medicine’s new patient service center business division, which encompasses the organization’s more than 60 patient service centers, including phlebotomy services. In this role, Fanning is responsible for its overall management, operations and financial performance in this role.  Follow Brian

As we position HNL Lab Medicine for accelerated growth, it’s essential that bring the voice of the organizational customer and the voice of the patient into every decision we make at the executive table,” said Martin Till president and CEO. “Kim and Brian bring deep understanding of the needs of these essential stakeholders who trust and depend on us. We look forward to their leadership in guiding our teams so we can exceed expectations every day.”